CIK 0001557376
- Non-accelerated filer
- Smaller reporting company
Zeo ScientifiX, Inc.
Sign in to watch- Ticker
- ZEOX
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 474180540
- Phone
- +1 888-963-7881
- Business address
- 3321 COLLEGE AVENUE, SUITE 246, DAVIE, FL, 33314
- Former names
- Organicell Regenerative Medicine, Inc., Biotech Products Services & Research, Inc., BESPOKE TRICYCLES INC
- 4 Grant or award Chief Science Officer acquired 15,000,000 shares (grant or award)
- 4 Open-market buy Director bought 422,514 shares at $0.10 ($42,251)
- 4 Grant or award Chief Financial Officer acquired 15,000,000 shares (grant or award)
- 4/A Grant or award Chief Financial Officer acquired 5,000,000 shares (grant or award)
- 4 Grant or award CEO and President acquired 15,000,000 shares (grant or award)
- 4 Grant or award Chief Science Officer acquired 28,000,000 shares (grant or award)
- 4 Grant or award Former Director acquired 736,808 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 28,000,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 23,500,000 shares (grant or award)
- 4 Grant or award CEO and President acquired 28,000,000 shares (grant or award)
- 4 Open-market buy Director bought 12,016,666 shares at an average $0.02 ($252,000)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Medical Officer acquired 5,000,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Grant or award Chief Financial Officer acquired 5,675,439 shares (grant or award)
- 4 Grant or award Chief Science Officer acquired 2,092,105 shares (grant or award)
- 4 Grant or award President acquired 2,092,105 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 9 of 10 · 197 filings